Analyze Diet

Topic:Biological Half-Life

Biological half-life refers to the time required for a substance to decrease by half in its concentration within the body. In horses, understanding the biological half-life of various substances, such as medications, nutrients, or toxins, is important for determining dosing schedules, withdrawal times, and potential effects on equine health. The biological half-life can vary significantly depending on the substance in question, as well as factors such as the horse's metabolism, age, and health status. This page compiles peer-reviewed research studies and scholarly articles that explore the biological half-life of different substances in horses, examining factors that influence these rates and their implications for veterinary medicine and equine management.
Pharmacokinetics, pharmacodynamics, and metabolism of acepromazine following intravenous, oral, and sublingual administration to exercised Thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    February 18, 2018   Volume 41, Issue 4 522-535 doi: 10.1111/jvp.12494
Knych HK, Seminoff K, McKemie DS, Kass PH.Acepromazine is a tranquilizer used commonly in equine medicine. This study describes serum and urine concentrations and the pharmacokinetics and pharmacodynamics of acepromazine following intravenous, oral, and sublingual (SL) administration. Fifteen exercised adult Thoroughbred horses received a single intravenous, oral, and SL dose of 0.09 mg/kg of acepromazine. Blood and urine samples were collected at time 0 and at various times for up to 72 hr and analyzed for acepromazine and its two major metabolites (2-(1-hydroxyethyl) promazine and 2-(1-hydroxyethyl) promazine sulfoxide) using liqu...
Pharmacokinetics, disposition, and plasma concentrations of dimethyl sulfoxide (DMSO) in the horse following topical, oral, and intravenous administration.
Journal of veterinary pharmacology and therapeutics    January 14, 2018   Volume 41, Issue 3 384-392 doi: 10.1111/jvp.12476
Soma LR, Robinson MA, You Y, Boston RC, Rudy J.Compartmental models were used to investigate the pharmacokinetics of intravenous (i.v.), oral (p.o.), and topical (TOP) administration of dimethyl sulfoxide (DMSO). The plasma concentration-time curve following a 15-min i.v. infusion of DMSO was described by a two-compartment model. Median and range of alpha (t ) and beta (t ) half-lives were 0.029 (0.026-0.093) and 14.1 (6.6-16.4) hr, respectively. Plasma concentration-time curves of DMSO following p.o. and TOP administration were best described by one-compartment absorption and elimination models. Following the p.o. administration, median a...
Pharmacokinetics of the anticonvulsant levetiracetam in neonatal foals.
Equine veterinary journal    December 30, 2017   Volume 50, Issue 4 532-536 doi: 10.1111/evj.12790
MacDonald KD, Hart KA, Davis JL, Berghaus LJ, Giguère S.Seizures are a common manifestation of neurological disease in the neonatal foal and are an important cause of morbidity and mortality in this population. Current antiepileptic options are effective, but often have undesirable adverse effects, short duration of action and high cost. Levetiracetam has an ideal safety and pharmacokinetic profile in multiple species, including the adult horse, and may be a safe and cost-effective alternative anticonvulsant in neonatal foals. Due to differences in drug disposition and clearance dosages in neonates, dosing recommendations in other species or adult ...
Pulmonary disposition and pharmacokinetics of minocycline in adult horses.
American journal of veterinary research    October 28, 2017   Volume 78, Issue 11 1319-1328 doi: 10.2460/ajvr.78.11.1319
Echeverria KO, Lascola KM, Giguère S, Foreman JH, Austin SA.OBJECTIVE To determine pharmacokinetics and pulmonary disposition of minocycline in horses after IV and intragastric administration. ANIMALS 7 healthy adult horses. PROCEDURES For experiment 1 of the study, minocycline was administered IV (2.2 mg/kg) or intragastrically (4 mg/kg) to 6 horses by use of a randomized crossover design. Plasma samples were obtained before and 16 times within 36 hours after minocycline administration. Bronchoalveolar lavage (BAL) was performed 4 times within 24 hours after minocycline administration for collection of pulmonary epithelial lining fluid (PELF) and BAL ...
Postoperative pharmacokinetics of meloxicam in horses after surgery for colic syndrome.
Journal of veterinary pharmacology and therapeutics    October 22, 2017   Volume 41, Issue 3 369-373 doi: 10.1111/jvp.12461
Di Salvo A, Giorgi M, Nannarone S, Lee HK, Corsalini J, Della Rocca G.NSAIDs are often used in horses with colic syndrome during the postoperative period, due to their ability to contrast endotoxemia and to promote an analgesic and anti-inflammatory effect. As the pharmacokinetics of a drug are often modified in unhealthy animals compared to healthy subjects, the aim of this study was to evaluate the pharmacokinetic profile of meloxicam after i.v. administration in horses undergoing laparotomy for colic syndrome. Eight horses received 0.6 mg/kg of meloxicam i.v. towards the end of surgery. Blood samples were taken at scheduled time points during the following 2...
Pharmacokinetics of furosemide administered 4 and 24 hours prior to high-speed exercise in horses.
Journal of veterinary pharmacology and therapeutics    October 22, 2017   Volume 41, Issue 2 224-229 doi: 10.1111/jvp.12458
Knych HK, Vale A, Wilson WD, Kass PH, Arthur RM, Jones JH.Furosemide is a diuretic agent used commonly in racehorses to attenuate the bleeding associated with exercise-induced pulmonary hemorrhage (EIPH). The current study describes serum and urine concentrations and the pharmacokinetics of furosemide following administration at 4 and 24 hrs prior to maximal exercise. Eight exercised adult Thoroughbred horses received a single IV administration of 250 mg of furosemide at 4 and 24 hrs prior to maximal exercise on a high-speed treadmill. Blood and urine samples were collected at time 0 and at various times for up to 72 hrs and furosemide concentrat...
Equine mesenchymal stem cells derived from endometrial or adipose tissue share significant biological properties, but have distinctive pattern of surface markers and migration.
Theriogenology    October 6, 2017   Volume 106 93-102 doi: 10.1016/j.theriogenology.2017.09.035
Cabezas J, Rojas D, Navarrete F, Ortiz R, Rivera G, Saravia F, Rodriguez-Alvarez L, Castro FO.Adult stromal mesenchymal stem cells (MSCs) have been postulated as responsible for cell renewal in highly and continuously regenerative tissues such as the endometrium. MSCs have been identified in the endometrium of many species including humans, rodents, pets and some farm animals, but not in horses. The objective of this work was to isolate such cells from the endometrium of mares and to compare their main biological attributes with horse adipose-derived MSCs. Here we successfully isolated and characterized endometrial MSCs (eMSCs) from mares. Said cells showed fibroblast-like morphology, ...
Pharmacokinetics of ceftazidime after regional limb perfusion in standing horses.
Veterinary surgery : VS    September 27, 2017   Volume 46, Issue 8 1120-1125 doi: 10.1111/vsu.12720
Oreff GL, Tatz AJ, Dahan R, Segev G, Haberman S, Britzi M, Kelmer G.To determine the metacarpophalangeal joint fluid concentrations of ceftazidime administered via regional limb perfusion (RLP). Methods: Eight healthy horses. Methods: RLP was performed by injecting 2 g of ceftazidime and 60 mL of perfusate volume in the cephalic vein of standing, sedated horses. Serum and synovial fluid from the metacarpophalangeal joint were collected before perfusion and at 0.5, 2, 6, 12, 24 hours postperfusion. Ceftazidime concentrations were measured via liquid chromatography. Maximal concentration (C ), area under the curve (AUC), half-life of the drug (T ½), and the tim...
Pharmacokinetics and pharmacodynamics of meldonium in exercised thoroughbred horses.
Drug testing and analysis    August 1, 2017   Volume 9, Issue 9 1392-1399 doi: 10.1002/dta.2214
Knych HK, Stanley SD, McKemie DS, Arthur RM, Bondesson U, Hedeland M, Thevis M, Kass PH.Although developed as a therapeutic medication, meldonium has found widespread use in human sports and was recently added to the World Anti-Doping Agency's list of prohibited substances. Its reported abuse potential in human sports has led to concern by regulatory authorities about the possible misuse of meldonium in equine athletics. The potential abuse in equine athletes along with the limited data available regarding the pharmacokinetics and pharmacodynamics of meldonium in horses necessitates further study. Eight exercised adult thoroughbred horses received a single oral dose of 3.5, 7.1, ...
Pharmacokinetics of chloramphenicol base after oral administration in adult horses.
Journal of the American Veterinary Medical Association    June 18, 2017   Volume 251, Issue 1 90-94 doi: 10.2460/javma.251.1.90
McElligott EM, Sommardahl CS, Cox SK.OBJECTIVE To determine the pharmacokinetics of chloramphenicol base after PO administration at a dose of SO mg/kg (22.7 mg/lb) in adult horses from which food was not withheld. DESIGN Prospective crossover study. ANIMALS 5 adult mares. PROCEDURES Chloramphenicol base (SO mg/kg) was administered PO to each horse, and blood samples were collected prior to administration (0 minutes) and at 5, 10, 15, and 30 minutes and 1, 2, 4, 8, and 12 hours thereafter. Following a washout period, chloramphenicol sodium succinate (25 mg/kg [11.4 mg/lb]) was administered IV to each horse, and blood samples were ...
Disposition of levetiracetam in healthy adult horses.
Journal of veterinary pharmacology and therapeutics    May 15, 2017   Volume 41, Issue 1 92-97 doi: 10.1111/jvp.12417
Cesar FB, Stewart AJ, Boothe DM, Ravis WR, Duran SH, Wooldridge AA.Nine horses received 20 mg/kg of intravenous (LEV ); 30 mg/kg of intragastric, crushed immediate release (LEV ); and 30 mg/kg of intragastric, crushed extended release (LEV ) levetiracetam, in a three-way randomized crossover design. Crushed tablets were dissolved in water and administered by nasogastric tube. Serum samples were collected over 48 hr, and levetiracetam concentrations were determined by immunoassay. Mean ± SD peak concentrations for LEV and LEV were 50.72 ± 10.60 and 53.58 ± 15.94 μg/ml, respectively. The y-intercept for IV administration was 64.54 ± 24.99 μg...
Pharmacokinetics of firocoxib after intravenous administration of multiple consecutive doses in neonatal foals.
Journal of veterinary pharmacology and therapeutics    April 29, 2017   Volume 40, Issue 6 e23-e29 doi: 10.1111/jvp.12410
Wilson KE, Davis JL, Crisman MV, Kvaternick V, Zarabadipour C, Cheramie H, Hodgson DR.The purpose of this study was to determine the pharmacokinetic profile of intravenous firocoxib in neonatal foals. Six healthy foals were administered 0.09 mg/kg firocoxib intravenously once a day for 7 days. Blood was collected for plasma firocoxib analysis using high-performance liquid chromatography with fluorescence detection at times 0 (day 1 of study only) and 0.08, 0.25, 1, 2, 4, 6, 8, 16 and 24 hr on dose numbers 1, 5 and 7. Blood was also collected immediately prior to doses 3, 4, 5 and 7. Final samples were collected at 36, 48, 72 and 96 hr following the final dose. Noncompartmen...
Pharmacokinetics of ceftiofur sodium in equine pregnancy.
Journal of veterinary pharmacology and therapeutics    March 19, 2017   Volume 40, Issue 6 656-662 doi: 10.1111/jvp.12399
Macpherson ML, Giguère S, Pozor MA, Runcan E, Vickroy TW, Benson SA, Troedsson MHT, Hatzel JN, Larson J, Vanden Berg E, Kelleman AA, Sanchez LC....Eleven pregnant pony mares (D270-326) were administered ceftiofur sodium intramuscularly at 2.2 mg/kg (n = 6) or 4.4 mg/kg (n = 5), once daily. Plasma was obtained prior to ceftiofur administration and at 0.5, 1, 2, 4, 8, 12, and 24 hr after administration. Eight pony mares were re-enrolled in the study at least 3 days from expected foaling to ensure steady-state concentrations of drug at the time of foaling. Mares were administered ceftiofur sodium (4.4 mg/kg, IM) daily until foaling. Parturition was induced using oxytocin 1 hr after ceftiofur sodium administration. Allantoic and am...
Pharmacokinetics of betamethasone in plasma, urine, and synovial fluid following intra-articular administration to exercised thoroughbred horses.
Drug testing and analysis    March 7, 2017   Volume 9, Issue 9 1385-1391 doi: 10.1002/dta.2170
Knych HK, Stanley SD, Harrison LM, Mckemie DS.The use of corticosteroids, such as betamethasone, in performance horses is tightly regulated. The objective of the current study was to describe the plasma pharmacokinetics of betamethasone as well as time-related urine and synovial fluid concentrations following intra-articular administration to horses. Twelve racing-fit adult Thoroughbred horses received a single intra-articular administration (9 mg) of a betamethasone sodium phosphate and betamethasone acetate injectable suspension into the right antebrachiocarpal joint. Blood, urine, and synovial fluid samples were collected prior to and...
Nonsteroidal Anti-inflammatory Drug Use in Horses.
The Veterinary clinics of North America. Equine practice    February 9, 2017   Volume 33, Issue 1 1-15 doi: 10.1016/j.cveq.2016.11.001
Knych HK.Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective anti-inflammatory and analgesic agents and are arguably the most commonly used class of drugs in equine medicine. This article provides a brief review of the mechanism of action, therapeutic uses, pharmacokinetics, and adverse effects associated with their use in horses. The use of COX-2 selective NSAIDs in veterinary medicine has increased over the past several years and special emphasis is given to the use of these drugs in horses. A brief discussion of the use of NSAIDs in performance horses is also included.
The Analysis of Phenylbutazone and Its Active Metabolite, Oxyphenbutazone, in Equine Tissues (Muscle, Kidney, and Liver), Urine, and Serum by LC-MS/MS.
Journal of AOAC International    February 1, 2017   Volume 100, Issue 4 1110-1122 doi: 10.5740/jaoacint.16-0127
Boison JO, Dowling P, Matus JL, Kinar J, Johnson R.This study reports the use of two validated LC with tandem MS (MS/MS) methods to study the residue depletion profile of phenylbutazone (PBZ) and its metabolite oxyphenbutazone (OXPBZ) from equine serum, urine, and muscle, kidney, and liver tissues. One LC-MS/MS method, with an LOQ of 1.0 ng/mL for PBZ and 2.0 ng/mL for OXPBZ, was used for the analysis of the two drugs in the biological fluids (equine urine and serum); the other LC-MS/MS method, with an LOQ of 0.5 ng/g for PBZ and OXPBZ, was used for the analysis of the drugs in the equine tissue samples. PBZ was administered intravenously to t...
Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses.
BMC veterinary research    January 19, 2017   Volume 13, Issue 1 28 doi: 10.1186/s12917-017-0955-1
Buntenkötter K, Osmers M, Schenk I, Schänzer W, Machnik M, Düe M, Kietzmann M.Although acetylsalicylic acid (ASA) is not frequently used as a therapeutic agent in horses, its metabolite SA is of special interest in equestrianism since it is a natural component of many plants used as horse feed. This led to the establishment of thresholds by horse sport organizations for SA in urine and plasma. The aim of this study was to investigate plasma and urine concentrations of salicylic acid (SA) after oral administration of three different single dosages (12.5 mg/kg, 25 mg/kg and 50 mg/kg) of acetylsalicylic acid (ASA) to eight horses in a cross-over designed study. Results:...
Pharmacokinetics of oral terbinafine in adult horses.
Journal of veterinary pharmacology and therapeutics    November 24, 2016   Volume 40, Issue 4 342-347 doi: 10.1111/jvp.12367
Younkin TJ, Davis EG, Kukanich B.The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o. terbinafine administered with p.o. cimetidine in healthy adult horses. The second objective was to assess the pharmacokinetics of terbinafine when administered per rectum in two different suspensions at 30 mg/kg to adult horses. Six healthy adult horses were included in this crossover study. Plasma terbinafine concentrations were quantified with liquid chromatography and mass spectrometry. The half-life (geometric mean) was 8.38 and 10.76 h, for p.o. alone and p.o. with cimetidine, respectively....
Pharmacokinetics and toxicity of intravenously administered lithium chloride in horses.
Veterinary anaesthesia and analgesia    November 16, 2016   Volume 27, Issue 2 108 doi: 10.1016/S1467-2987(16)31361-7
Hatfield C, McDonell W, Black W.No abstract available
Erratum to: Viability of equine mesenchymal stem cells during transport and implantation.
Stem cell research & therapy    November 9, 2016   Volume 7, Issue 1 161 doi: 10.1186/s13287-016-0423-z
Garvican ER, Cree S, Bull L, Smith RK, Dudhia J.No abstract available
Comparison of the pharmacokinetics of two formulations of hydroxyethyl starch in healthy horses.
Journal of veterinary pharmacology and therapeutics    September 21, 2016   Volume 40, Issue 3 309-313 doi: 10.1111/jvp.12359
Epstein KL, Bergren A, Nie B, Arnold RD, Brainard BM.A lower molecular weight and molar substitution formulation (130/0.4) of hydroxyethyl starch solution has been shown to have a more sustained effect on COP and similar hemodynamic effects as a higher molecular weight and molar substitution formulation (600/0.75) in healthy horses. In humans, these pharmacodynamic characteristics are coupled with more rapid clearance and decreased adverse coagulation effects and accumulation. The objective of this study was to determine and compare the pharmacokinetics of these two formulations in horses. Eight healthy horses were given a 10 mL/kg bolus of eac...
Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses.
Journal of veterinary pharmacology and therapeutics    September 18, 2016   Volume 40, Issue 3 239-247 doi: 10.1111/jvp.12362
Uney K, Altan F, Altan S, Erol H, Arican M, Elmas M.The plasma and synovial fluid pharmacokinetics and safety of cefquinome, a 2-amino-5-thiazolyl cephalosporin, were determined after multiple intravenous administrations in sixteen healthy horses. Cefquinome was administered to each horse through a slow i.v. injection over 20 min at 1, 2, 4, and 6 mg/kg (n = 4 horses per dose) every 12 h for 7 days (a total of 13 injections). Serial blood and synovial fluid samples were collected during the 12 h after the administration of the first and last doses and were analyzed by a high-performance liquid chromatography assay. The data were evaluate...
Comparison of a modified phenol/chloroform and commercial-kit methods for extracting DNA from horse fecal material.
Journal of microbiological methods    July 25, 2016   Volume 129 14-19 doi: 10.1016/j.mimet.2016.07.019
Janabi AHD, Kerkhof LJ, McGuinness LR, Biddle AS, McKeever KH.There are many choices for methods of extracting bacterial DNA for Next Generation Sequencing (NGS) from fecal samples. Here, we compare our modifications of a phenol/chloroform extraction method plus an inhibitor removal solution (C3) (ph/Chl+C3) to the PowerFecal® DNA Isolation Kit (MoBio-K). DNA quality and quantity coupled to NGS results were used to assess differences in relative abundance, Shannon diversity index, unique species, and principle coordinate analysis (PCoA) between biological replicates. Six replicate samples, taken from a single ball of horse feces manually collected from ...
Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction.
Journal of veterinary pharmacology and therapeutics    June 15, 2016   Volume 40, Issue 2 158-164 doi: 10.1111/jvp.12339
McFarlane D, Banse H, Knych HK, Maxwell LK.The objective of this study was to gain an understanding of the pharmacokinetic and pharmacodynamic properties of pergolide in horses with PPID after of long-term oral administration. Six horses with confirmed PPID were treated with pergolide (Prascend ) at 1 mg/horse po q24 h for 2 months, followed by 2 mg/horse po q24 h for 4 months. Following the last dose, plasma samples were collected for measurement of pergolide using an LC/MS/MS method and ACTH measurement using a chemiluminescent immunoassay. Noncompartmental and compartmental pharmacokinetic analyses were performed, as well as p...
Blood concentrations of remifentanil during and after infusion in horses anesthetized with isoflurane and dexmedetomidine.
Research in veterinary science    June 14, 2016   Volume 107 202-206 doi: 10.1016/j.rvsc.2016.06.008
Benmansour P, Billinsky J, Duke-Novakovski T, Alcorn J.To determine blood remifentanil concentration in isoflurane-anesthetized horses during and after a 1h remifentanil and dexmedetomidine infusion. Methods: Prospective study. Methods: Six adult mixed breed horses with (mean±SD) bodyweight of 507±61kg and 14±4years of age. Methods: Following sedation with xylazine IV, anesthesia was induced with ketamine IV mixed with diazepam IV. Anesthesia was maintained with isoflurane in oxygen. After 52±7min for instrumentation, dexmedetomidine (0.25μgkg(-1) followed by 1.0μg(-1)kg(-1)h(-1)) and remifentanil infusions (6μgkg(-1)h(-1)) were administere...
Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    June 13, 2016   Volume 40, Issue 1 92-96 doi: 10.1111/jvp.12328
Knych HK, Stanley SD, Arthur RM, McKemie DS.The use of anti-ulcer medications, such as cimetidine, ranitidine, and omeprazole, is common in performance horses. The use of these drugs is regulated in performance horses, and as such a withdrawal time is necessary prior to competition to avoid a medication violation. To the authors' knowledge, there are no reports in the literature describing repeated oral administrations of these drugs in the horse to determine a regulatory threshold and related withdrawal time recommendations. Therefore, the objective of the current study was to describe the disposition and elimination pharmacokinetics o...
Pharmacokinetics of ketoprofen enantiomers following intravenous and oral administration to exercised Thoroughbred horses.
Veterinary journal (London, England : 1997)    May 7, 2016   Volume 207 196-198 doi: 10.1016/j.tvjl.2015.09.018
Knych HK, Arthur RM, Steinmetz S, McKemie DS.Ketoprofen (KTP) is currently only available as an injectable formulation for intravenous administration to horses. The primary goal of the study reported here was to characterize the pharmacokinetics of KTP, including determination of bioavailability following oral administration of the currently available injectable formulation as well as a paste formulation. KTP was administered intravenously and orally, and blood and urine samples were collected at various time points up to 96 h. KTP enantiomer concentrations were determined using LC–MS/MS, and pharmacokinetic analyses were performed. Me...
Elimination of cetirizine following administration of multiple doses to exercised thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    April 28, 2016   Volume 39, Issue 5 522-524 doi: 10.1111/jvp.12318
Knych HK, Stanley SD, Arthur RM, McKemie DS.Cetirizine is an antihistamine used in performance horses for the treatment of hypersensitivity reactions and as such a withdrawal time is necessary prior to competition. The objective of the current study was to describe the disposition and elimination of cetirizine following oral administration in order to provide additional serum concentration data upon which appropriate regulatory recommendations can be established. Nine exercised thoroughbred horses were administered 0.4 mg/kg of cetirizine orally BID for a total of five doses. Blood samples were collected immediately prior to drug admin...
Pharmacokinetics of guaifenesin following administration of multiple doses to exercised Thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    January 14, 2016   Volume 39, Issue 4 416-419 doi: 10.1111/jvp.12287
Knych HK, Stanley SD, Benson D, Arthur RM.Guaifenesin is an expectorant commonly used in performance horses to aid in the clearance of mucus from the airways. Guaifenesin is also a centrally acting skeletal muscle relaxant and as such is a prohibited drug with withdrawal necessary prior to competition. To the authors' knowledge, there are no reports in the literature describing single or multiple oral administrations of guaifenesin in the horse to determine a regulatory threshold and related withdrawal time. Therefore, the objective of the current study was to describe the pharmacokinetics of guaifenesin following oral administration ...
The Equine Embryo Influences Immune-Related Gene Expression in the Oviduct.
Biology of reproduction    January 6, 2016   Volume 94, Issue 2 36 doi: 10.1095/biolreprod.115.136432
Smits K, De Coninck DI, Van Nieuwerburgh F, Govaere J, Van Poucke M, Peelman L, Deforce D, Van Soom A.Although the equine oviduct clearly affects early embryo development and the selective transport of equine embryos through the oviduct indicates a reciprocal interaction, the influence of the embryo on gene expression in the oviduct remains to be determined in the horse. The aim of this study was to examine this by means of RNA sequencing. Four days after ovulation, epithelial cells ipsilateral and contralateral to the ovulation side from five cyclic and five pregnant mares were collected from the oviduct. RNA was extracted, samples were sequenced, and data analysis was performed to determine ...